E910-0147 Screening compound: 5-{3-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-3-oxopropyl}-3-(4-fluorophenyl)-4H,5H-[1,2]oxazolo[5,4-d]pyrimidin-4-one

E910-0147 Screening compound: 5-{3-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-3-oxopropyl}-3-(4-fluorophenyl)-4H,5H-[1,2]oxazolo[5,4-d]pyrimidin-4-one
E910-0147 Screening compound: 5-{3-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-3-oxopropyl}-3-(4-fluorophenyl)-4H,5H-[1,2]oxazolo[5,4-d]pyrimidin-4-one alternative view

Chemical Structure Depiction of ChemDiv screening compound E910-0147
5-{3-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-3-oxopropyl}-3-(4-fluorophenyl)-4H,5H-[1,2]oxazolo[5,4-d]pyrimidin-4-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E910-0147

Molecular Formula

C25H23ClFN5O3 (C25 H23 ClFN5 O3)

Compound Name

5-{3-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-3-oxopropyl}-3-(4-fluorophenyl)-4H,5H-[1,2]oxazolo[5,4-d]pyrimidin-4-one

IUPAC name

5-{3-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]-3-oxopropyl}-3-(4-fluorophenyl)-4H5H-[12]oxazolo[54-d]pyrimidin-4-one

SMILES

Cc(ccc(Cl)c1)c1N(CC1)CCN1C(CCN(C=Nc1c2c(-c(cc3)ccc3F)no1)C2=O)=O

InChI

InChI=1S/C25H23ClFN5O3/c1-16-2-5-18(26)14-20(16)30-10-12-31(13-11-30)21(33)8-9-32-15-28-24-22(25(32)34)23(29-35-24)17-3-6-19(27)7-4-17/h2-7,14-15H,8-13H2,1H3

InChI Key

HNLHFLGOLZMCAJ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14927159

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

495.94

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.470

Distribution Coefficient, logD

3.470

Water Solubility, LogSw

-4.42

Polar Surface Area

67.032

Acid Dissociation Constant (pKa)

23.94

Base Dissociation Constant (pKb)

3.34

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

28.00

E910-0147 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with E910-0147 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E910-0147?
Check Price and Availability of E910-0147, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E910-0147 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E910-0147
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E910-0147
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E910-0147 available by request